CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
Jun Ho Yi, Jung Hun Kang, In Gyu Hwang, Hee Kyung Ahn, Hyun Jin Baek, Soon Il Lee, Do Hyoung Lim, Young-Woong Won, Jun Ho Ji, Hyo Song Kim, Sun Young Rha, Sung Yong Oh, Kyung Eun Lee, Taekyu Lim, Chi Hoon Maeng, Moon Jin Kim, Seung Tae Kim, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Se Hoon Park
Cancer Research and Treatment. 2016;48(2):553-560.   Published online 2015 August 10    DOI: https://doi.org/10.4143/crt.2015.155

Excel Download

A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
Cancer Research and Treatment. 2016;48(2):553-560   Crossref logo
Link1 Link2 Link3

P-057 A retrospective analysis for patients with HER2 positive gastric cancer who were treated with trastuzumab-based chemotherapy
Annals of Oncology. 2015;26:iv16   Crossref logo
Link1 Link2 Link3

Tumor-infiltrating lymphocytes in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or the combination: a meta-analysis of published randomized clinical trials
The Breast. 2017;32:S105   Crossref logo
Link1 Link2

Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy
Drugs. 2014;74(6):675-686   Crossref logo
Link1 Link2 Link3

Erratum to: Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
Journal of Gastroenterology. 2016;51(5):509-510   Crossref logo
Link1 Link2 Link3

Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
Journal of Gastroenterology. 2015;50(9):955-961   Crossref logo
Link1 Link2 Link3

PCN116 ANALYSIS OF THE EQ-5D QUESTIONNAIRE FOR PATIENTS WITH ADVANCED HER2-POSITIVE GASTRIC CANCER (HER2+ AGC) BASED ON THE TRASTUZUMAB FOR GASTRIC CANCER (TOGA) STUDY
Value in Health. 2010;13(7):A273   Crossref logo
Link1 Link2

Prognostic Impact of Her2 Immunoreactivity in Her2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy
Annals of Oncology. 2014;25:v52   Crossref logo
Link1 Link2 Link3

Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy
Surgical Case Reports. 2020;6(1):   Crossref logo
Link1 Link2 Link3

Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: A Cohort study
. 2020;   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.